| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 216,018 | 222,340 | 219,483 | 220,353 | | Cost of Revenue | (176,001) | 176,001 |
-
| 92,090 | | | Gross Profit | 392,019 | 46,339 | 219,483 | 128,263 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 270,255 | (81,471) | 94,108 | 15,960 | | Non Recurring |
-
| 20,302 |
-
| 57,899 | | Others | 53,558 | 53,750 | 52,627 | 51,164 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (39,630) | 53,758 | 72,748 | 3,240 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 241 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (43,338) | 54,250 | 76,205 | 3,734 | | Interest Expense | 41,205 | 37,474 | 29,157 | 29,256 | | Income Before Tax | (84,543) | 16,776 | 47,048 | (25,522) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 1,329 |
-
|
-
| 257 | | | | Net Income From Continuing Ops | 27,432 | 16,776 | 47,048 | (25,522) | | | Non-recurring Events | | Discontinued Operations | 30,668 | (53) | 53 | 27,645 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 59,429 | 16,723 | 47,101 | 2,123 | | Preferred Stock And Other Adjustments | (1,275) | 951 | 324 | (3,929) | | | Net Income Applicable To Common Shares | $58,154 | $17,674 | $47,425 | ($1,806) |
|
0.51% Nasdaq 
Income Statement
